Cargando…

4-(3-Methylanilino)-N-[N-(1-methylethyl)carbamoyl]pyridinium-3-sulfonamidate (torasemide) methanol 0.25-solvate 0.25-hydrate

The title compound, C(16)H(20)N(4)O(3)S·0.25CH(4)O·0.25H(2)O, is a hydrate/methanol solvate of torasemide, a diuretic drug used in the treatment of hypertension. The asymmetric unit contains two torasemide molecules and half-occupied methanol and water molecules. It is isomorphous with the previou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartolucci, Gianluca, Bruni, Bruno, Coran, Silvia A., Di Vaira, Massimo
Formato:	Texto
Lenguaje:	English
Publicado:	International Union of Crystallography 2009
Materias:	Organic Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2977669/ https://www.ncbi.nlm.nih.gov/pubmed/21584012 http://dx.doi.org/10.1107/S160053680901160X

Ejemplares similares

4-(3-Methylanilino)-N-[N-(1-methylethyl)carbamoyl]pyridinium-3-sulfonamidate (torasemide T–N): a low temperature redetermination
por: Bartolucci, Gianluca, et al.
Publicado: (2009)

Ethyl (Z)-3-(4-methylanilino)-2-[(4-methylphenyl)carbamoyl]prop-2-enoate
por: Islor, Arun M., et al.
Publicado: (2012)

A Comparative Study of 0.25% Levobupivacaine, 0.25% Ropivacaine, and 0.25% Bupivacaine in Paediatric Single Shot Caudal Block
por: Sharma, Jagdeep, et al.
Publicado: (2018)

Evaluation of Photocatalytic Performance of Nano-Sized Sr(0.9)La(0.1)TiO(3) and Sr(0.25)Ca(0.25)Na(0.25)Pr(0.25)TiO(3) Ceramic Powders for Water Purification
por: Jovanoski Kostić, Aleksandra, et al.
Publicado: (2022)

1-Benzyl-3-methylimidazolium chloride 0.25-hydrate
por: Ji, Xiujie, et al.
Publicado: (2009)

(E)-Methyl N′-[(1H-indol-3-yl)methylidene]hydrazinecarboxylate 0.25-hydrate
por: Lv, Lu-Ping, et al.
Publicado: (2011)

Caudal Epidural Analgesia in Pediatric Patients: Comparison of 0.25% Levobupivacaine and 0.25% Ropivacaine in Terms of Motor Blockade and Postoperative Analgesia
por: Praveen, P., et al.
Publicado: (2017)

2-(4-Methylanilino)acetohydrazide
por: Fun, Hoong-Kun, et al.
Publicado: (2009)

Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)

A Comparative Study of Effect of 0.25% Levobupivacaine with Dexmedetomidine versus 0.25% Levobupivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block
por: Iyer, Lakshmi S., et al.
Publicado: (2021)

Exchange-bias via nanosegregation in novel Fe(2−x)Mn(1+x)Al (x = −0.25, 0, 0.25) Heusler films
por: Kurdi, S., et al.
Publicado: (2020)

(Z)-6-[(5-Chloro-2-hydroxyanilino)methylene]-4-methoxycyclohexa-2,4-dienone 0.25-hydrate
por: Özek, Arzu, et al.
Publicado: (2009)

4-[(4-Methylanilino)methyl]benzonitrile
por: Wei, Bin
Publicado: (2011)

Peculiar Properties of the La(0.25)Ba(0.25)Sr(0.5)Co(0.8)Fe(0.2)O(3−δ) Perovskite as Oxygen Reduction Electrocatalyst
por: Aliotta, Chiara, et al.
Publicado: (2023)

Potential outstanding physical properties of novel black arsenic phosphorus As(0.25)P(0.75)/As(0.75)P(0.25) phases: a first-principles investigation
por: Liu, Fangqi, et al.
Publicado: (2022)

KNb(1.75)V(0.25)PS(10)
por: Yu, Jaemin, et al.
Publicado: (2011)

Treatment of angiokeratomas of Fordyce with topical rapamycin 0.25% cream
por: Bell, Katheryn A., et al.
Publicado: (2020)

Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)

2-(2-Methylanilino)-N′-(propan-2-ylidene)acetohydrazide
por: Salim, Muhammad, et al.
Publicado: (2009)

4-Methyl-2-(2-methylanilino)benzoic acid
por: Liu, Chenxin, et al.
Publicado: (2023)

2,6-Di-tert-butyl-4-[(N-methylanilino)methyl]phenol
por: Zeng, Tao, et al.
Publicado: (2008)

N-[2-(2,2-Dimethylpropanamido)pyrimidin-4-yl]-2,2-dimethylpropanamide n-hexane 0.25-solvate hemihydrate
por: Ośmiałowski, Borys, et al.
Publicado: (2013)

The CMS tracker APV25 $0.25 \mu m$ CMOS readout chip
por: Raymond, M, et al.
Publicado: (2000)

Possible quadrupole-first options with $\beta^* \leq$ 0.25M
por: Koutchouk, Jean-Pierre
Publicado: (2006)

Standard of Spectral Radiance for the Region of 0.25 to 2.6 Microns
por: Stair, Ralph, et al.
Publicado: (1960)

Experiments on MEMS Integration in 0.25 μm CMOS Process
por: Michalik, Piotr, et al.
Publicado: (2018)

Cataract Surgery by Intraoperative Surface Irrigation with 0.25% Povidone–Iodine
por: Shimada, Hiroyuki, et al.
Publicado: (2021)

Ultrasound guided peritubal infiltration of 0.25% Bupivacaine versus 0.25% Ropivacaine for postoperative pain relief after percutaneous nephrolithotomy: A prospective double blind randomized study
por: Parikh, Geeta P, et al.
Publicado: (2014)

Wall-plug power of 2x0.25 TeV CLIC
por: Hübner, K
Publicado: (1992)

3,4-Dinitro-1H-pyrazole benzene 0.25-solvate
por: Li, Yong-Xiang, et al.
Publicado: (2011)

2,3,4-Trihydroxybenzoic acid 0.25-hydrate
por: Li, Jin-Hang, et al.
Publicado: (2012)

Wall-plug power of 2x0.25 TeV CLIC
por: Hübner, K
Publicado: (1992)

Design of a comparator in a 0.25 $\mu m$ CMOS technology
por: Van Bakel, N, et al.
Publicado: (2000)

The 0.25um Token Bit Manager Chip for the CMS Pixel Readout
por: Bartz, Edward
Publicado: (2005)

(E)-N′-(4-Pyridylmethylene)-4-(8-quinolyloxy)butanohydrazide 0.25-hydrate
por: Chen, Min-E, et al.
Publicado: (2009)

A Wideband True Time Delay Circuit Using 0.25 µm GaN HEMT Technology
por: Kim, Jeong-Geun, et al.
Publicado: (2023)

3-(2-Amino-5-nitroanilino)-5,5-dimethylcyclohex-2-en-1-one 0.25-hydrate
por: Mehdi, Sayed Hasan, et al.
Publicado: (2010)

A quantitative approach for trap analysis between Al(0.25)Ga(0.75)N and GaN in high electron mobility transistors
por: Amir, Walid, et al.
Publicado: (2021)

Methyl 4-[N-(5-bromopyrimidin-2-yl)carbamoyl]benzoate
por: Hu, Hui-Ling, et al.
Publicado: (2012)

Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia: A Pilot, Randomized Open-Label Study
por: Bharadwaj, Apoorva V, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_80fkvo14etr3k1fvej1rlg000c